期刊文献+

AMH在多囊卵巢综合征中的研究进展 被引量:28

Research progress of role of AMH in polycystic ovarian syndrome
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是一种常见的妇科内分泌、代谢紊乱性疾病,同时也是一种生殖障碍性疾病,严重危害女性身心健康,但是其具体发病机制目前仍不明确。越来越多的研究证明,抗苗勒氏管激素(AMH)与卵泡生长发育、卵泡募集与成熟、高雄激素血症、胰岛素抵抗等均具有密切关系,在PCOS的发生发展过程中也具有重要调节作用。因此,本文结合AMH与PCOS的最新研究进行综述,以期探讨二者关系及其潜在发病机制,为PCOS的诊治提供新的思路。 Polycystic ovarian syndrome(PCOS)is the most common endocrinopathy and reproductive system disorders in women,but its pathophysiology remains unclear.Nowadays,many studies have shown that anti-Müllerian hormone(AMH)is significantly related to follicular development,recruitment,hyperandrogenism and insulin resistance,which all contribute to the development of PCOS.Therefore,this paper reviews the relationship between AMH and PCOS to explore the potential mechanism of this syndrome for providing new ideas about the diagnosis and treatment of PCOS.
作者 陈洁 陈晨
出处 《生殖医学杂志》 CAS 2017年第5期490-493,共4页 Journal of Reproductive Medicine
关键词 多囊卵巢综合征 抗苗勒管激素 高雄激素 胰岛素抵抗 Polycystic ovarian syndrome Anti-Müllerian hormone Hyperandrogenism Insulin resistance
  • 相关文献

二级参考文献43

  • 1Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370: 685-697.
  • 2Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992; 167: 1807-1812.
  • 3Dunaif A, Sorbara L, Delson R, Green G. Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes 1993; 42: 1462-1468.
  • 4Norman R J, Masters S, Hague W, Beng C, Pannall P, Wang JX. Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil Steril 1995; 63: 329-335.
  • 5Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf) 2002; 57: 343-350.
  • 6Goodarzi MO, Erickson S, Port SC, Jennrich RI, Korenman SG. beta-Cell function: a key pathological determinant in polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90:310-315.
  • 7Kauffman RP, Baker VM, DiMarino P, Castracane VD. Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome. Fertil Steri12006; 85: 1010-1016.
  • 8Wijeyaratne CN, Nirantharakumar K, Balen AH, Barth JH, Sheriff R, Belchetz PE. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin Endocrinol (Oxf) 2004; 60: 560-567.
  • 9Kalra P, Bansal B, Nag P, Singh JK, Gupta RK, Kumar S, et al. Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome. Fertil Steril 2009; 91(4 Suppl): 1437-1440.
  • 10Sundararaman PG, Manomani R, Sridhar GR, Sridhar V, Sundaravalli A, Umachander M. Risk of atherosclerosis in women with polycystic ovary syndrome: a study from South India. Metab Syndr Relat Disord 2003; 1: 271-275.

共引文献10

同被引文献227

引证文献28

二级引证文献317

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部